Journal of Oral Science Research ›› 2020, Vol. 36 ›› Issue (5): 428-432.DOI: 10.13701/j.cnki.kqyxyj.2020.05.007

Previous Articles     Next Articles

Expression and Prognostic Significance of microRNAs in Peripheral Blood of Patients with Oral Squamous Cell Carcinoma

YANG Kaicheng1, YANG Lei1, ZHAO Jianguang1, LUO Fengyu2, CHEN Yanping1*, CUI Zifeng1, CHEN He1, MAN Shasha3   

  1. 1. Department of Stomatology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China;
    2. Department of Stomatology, People's Hospital of Lingshou County, Shijiazhuang 050500, China;
    3. Department of Stomatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China
  • Received:2019-08-02 Online:2020-06-16 Published:2020-06-18

Abstract: Objective: To screen differentially expressed microRNAs (miRNAs) in peripheral blood of patients with oral squamous cell carcinoma (OSCC) by qRT-PCR, and further to explore the relationship between differentially expressed miRNAs and clinical parameters and prognosis. Methods: The changes of miRNA in peripheral blood of patients with OSCC were observed by qRT-PCR, and the relationship between miRNA and clinicopathological parameters and prognosis was analyzed. Results: A total of 84 kinds of miRNAs were detected, of which 8 were up-regulated more than twice in peripheral blood of patients with OSCC and 18 were down-regulated less than 0.5 times. The expression of miR-222-3p and miR-423-5p in peripheral blood was significantly correlated with pTNM stage and lymph node metastasis (P<0.05). The patients with high expression of miR-222-3p and low expression of miR-423-5p had a worse prognosis (P<0.05). Multivariate analysis showed that the overexpression of miR-222-3p was an independent prognostic factor for the OSCC patients. Conclusions: miR-222-3p and miR-423-5p were abnormally expressed in the peripheral blood in OSCC patients, and they were expected to be biomarkers for early diagnosis and predicting prognosis of OSCC.

Key words: OSCC, miR-222-3p, miR-423-5p, biomarkers, prognosis